‏Dynamic contrast-enhanced MRI evaluation of pathologic complete response in human epidermal growth factor receptor 2 (HER2)-positive breast cancer after HER2-targeted therapy

RATIONALE AND OBJECTIVES: Pathologic complete response (pCR) in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer after HER2-targeted therapy correlates increased disease-free survival and decreased mastectomy rates. The aim of this study was to explore tumor shrin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Acad Radiol
Main Authors: Heacock, Laura, Lewin, Alana, Ayoola, Abimbola, Moccaldi, Melanie, Babb, James S., Kim, Sungheon G., Moy, Linda
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7416507/
https://ncbi.nlm.nih.gov/pubmed/31444111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.acra.2019.07.011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados